Cheen Hua Heng McVin, Lim Seng Han, Huang Ming Chien, Bee Yong Mong, Wee Hwee Lin
Department of Pharmacy, Singapore General Hospital, Singapore; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.
Department of Pharmacy, Singapore General Hospital, Singapore.
Clin Ther. 2014 Jul 1;36(7):1043-53. doi: 10.1016/j.clinthera.2014.05.009. Epub 2014 Jun 7.
The real-world clinical effectiveness of exogenous insulin is limited by nonadherence. Various insulin delivery systems have been developed to help improve adherence, with prefilled pens gaining popularity among adult Singaporeans with diabetes. However, adherence to insulin in people with diabetes in Singapore and most of Asia has not been studied.
This study aimed to compare adherence to premixed insulin formulated in a prefilled pen versus a vial/syringe and to identify predictors of adherence in 955 patients managed at the outpatient clinics of the largest acute care hospital in Singapore.
In this retrospective longitudinal study, electronic medical and pharmacy refill records were used to determine adherence to insulin over 24 months, measured in terms of compliance and persistence. Compliance is expressed as the medication possession ratio (used as continuous and categorical variables), and persistence is reported as a dichotomous variable with a permissible refill gap of 30 days before discontinuation of therapy is considered. Multivariate linear or logistic regression analysis was used to identify predictors of adherence.
Compared with prefilled pen users, vial/syringe users were older (mean [SD] age, 64.1 [10.6] vs 62.4 [11.9] years; P = 0.032), and more were undergoing polypharmacy (69.6% vs 54.1%; P < 0.001). The mean (SD) medication possession ratio was comparable in vial/syringe versus prefilled pen users (83.8% [26.9%] vs 86.0% [23.2%]; P = 0.266). Prefilled pen users were more persistent with therapy compared with vial/syringe users (odds ratio = 1.36; 95% CI, 1.01-1.86) after adjusting for sociodemographic and clinical covariates. Median time to discontinuation of therapy was comparable (vial/syringe vs prefilled pen: 409 vs 532 days; P = 0.076). Being managed by an endocrinologist and not receiving government subsidies were significant predictors of persistence.
Compared with other studies that found strong associations between adherence and insulin devices, the findings of this study suggest that persistence but not compliance varies by insulin device. The willingness to pay for health care, in addition to affordability, may affect insulin therapy adherence. Patients with uncontrolled diabetes due to suspected nonadherence may benefit from referral to a multidisciplinary care team comprising endocrinologists, diabetes nurse educators, dietitians, and allied health professionals. These findings are applicable to outpatients with similar demographic features managed at other acute care hospitals in Singapore. The impact of insulin devices on glycemic control needs to be investigated in future larger studies.
外源性胰岛素在现实世界中的临床疗效受到治疗依从性的限制。人们已开发出各种胰岛素给药系统来帮助提高依从性,预填充笔在新加坡成年糖尿病患者中越来越受欢迎。然而,新加坡及亚洲大部分地区糖尿病患者的胰岛素治疗依从性尚未得到研究。
本研究旨在比较预填充笔与小瓶/注射器配制的预混胰岛素的依从性,并确定新加坡最大的急症医院门诊管理的955例患者的依从性预测因素。
在这项回顾性纵向研究中,利用电子医疗和药房再填充记录来确定24个月内的胰岛素依从性,通过依从性和持续性来衡量。依从性用药物持有率表示(用作连续和分类变量),持续性报告为二分变量,在治疗中断前允许有30天的再填充间隔。采用多变量线性或逻辑回归分析来确定依从性的预测因素。
与预填充笔使用者相比,小瓶/注射器使用者年龄更大(平均[标准差]年龄,64.1[10.6]岁对62.4[11.9]岁;P = 0.032),且更多人正在接受多种药物治疗(69.6%对54.1%;P < 0.001)。小瓶/注射器使用者与预填充笔使用者的平均(标准差)药物持有率相当(83.8%[26.9%]对86.0%[23.2%];P = 0.266)。在调整社会人口统计学和临床协变量后,预填充笔使用者与小瓶/注射器使用者相比治疗持续性更高(优势比 = 1.36;95%置信区间,1.01 - 1.86)。治疗中断的中位时间相当(小瓶/注射器对预填充笔:409天对532天;P = 0.076)。由内分泌科医生管理且未获得政府补贴是持续性的重要预测因素。
与其他发现依从性与胰岛素装置之间有强关联的研究相比,本研究结果表明,持续性而非依从性因胰岛素装置而异。除了可承受性之外,支付医疗保健费用的意愿可能会影响胰岛素治疗依从性。因疑似依从性差而糖尿病控制不佳的患者可能受益于转诊至多学科护理团队,该团队由内分泌科医生、糖尿病护士教育者、营养师和相关健康专业人员组成。这些发现适用于新加坡其他急症医院管理的具有相似人口统计学特征的门诊患者。胰岛素装置对血糖控制的影响需要在未来更大规模的研究中进行调查。